AIM IMMUNOTECH INC. Gain (Loss) on Extinguishment of Debt
AIM IMMUNOTECH INC. (AIM) reported Gain (Loss) on Extinguishment of Debt of -$2.70 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-31
- AIM IMMUNOTECH INC. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- AIM IMMUNOTECH INC. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $0.00.
- AIM IMMUNOTECH INC. gain (loss) on extinguishment of debt for the quarter ending 2021-06-30 was -$2.70M.
- AIM IMMUNOTECH INC. gain (loss) on extinguishment of debt for the quarter ending 2020-12-31 was $0.00.
- AIM IMMUNOTECH INC. gain (loss) on extinguishment of debt for fiscal 2021 was -$2.70M, a 2002.11% decline from fiscal 2020.
- AIM IMMUNOTECH INC. gain (loss) on extinguishment of debt for fiscal 2020 was $142.00K.
- AIM IMMUNOTECH INC. gain (loss) on extinguishment of debt for fiscal 2019 was -$345.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | -$2.70M derived: sum of 3 quarters · filed 2023-03-31 | -$2.70M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$2.70M derived: sum of 2 quarters · filed 2022-11-14 | -$2.70M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$2.70M 10-Q · filed 2022-08-15 | -$2.70M 10-Q · filed 2022-08-15 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$203.00K derived: sum of 2 quarters · filed 2022-03-31 | -$203.00K derived: sum of 3 quarters · filed 2022-03-31 | $142.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$203.00K derived: sum of 2 quarters · filed 2021-11-15 | $142.00K 10-Q · filed 2021-11-15 | $345.00K 10-Q · filed 2020-11-12 | -$475.81K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $345.00K 10-Q · filed 2020-08-14 | -$272.81K derived: sum of 3 quarters · filed 2021-03-31 | -$272.81K derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2020-03-31 | $345.00K 10-Q · filed 2020-05-14 | -$272.81K derived: sum of 2 quarters · filed 2021-03-31 | -$272.81K derived: sum of 3 quarters · filed 2021-03-31 | -$272.81K derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2019-12-31 | -$617.81K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$617.81K derived: sum of 2 quarters · filed 2021-03-31 | -$617.81K derived: sum of 3 quarters · filed 2021-03-31 | -$345.00K 10-K · filed 2021-03-31 | $345.00K 10-K · filed 2020-03-30 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $272.81K 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $272.81K 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $272.81K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |